1-1 of 1
Lee Ann Dietz, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial of TGR-1202, a Next Generation Once Daily PI3K-Delta Inhibitor in Combination with Obinutuzumab Plus Chlorambucil, in Patients with Chronic Lymphocytic Leukemia

Daruka Mahadevan, MD PhD, Emily K. Pauli, BMBS, PharmD, Kathy Cutter, RN, BSN, Lee Ann Dietz, RN, Peter Sportelli, Hari P. Miskin, MS, Marshall T. Schreeder, MD
Journal: Blood
Blood (2015) 126 (23): 2942.
https://doi.org/10.1182/blood.V126.23.2942.2942
Published: 2015